Company Sabin & Weil Rx Srl with Fiscal Code 16960515
recorded a turnover of 2024 of
292.167,
with a net profit of
21.540
and having an average number of employees of
3.
The company operates in the field of Activităţi de asistenţă stomatologică having the NACE code 8623.
Sales - Ron
Sales, Profit, Employees, Total Income, Financial Results -
Sabin & Weil Rx Srl
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Sales - EUR
291.219
287.802
332.951
254.351
355.439
329.985
425.919
414.881
397.713
292.167
Total Income - EUR
303.588
300.281
332.958
254.377
355.528
333.173
460.841
416.988
402.916
293.485
Total Expenses - EUR
187.290
212.129
227.566
200.187
272.645
203.890
263.174
256.858
296.534
263.064
Gross Profit/Loss - EUR
116.298
88.152
105.392
54.191
82.883
129.283
197.667
160.130
106.382
30.421
Net Profit/Loss - EUR
96.220
71.315
97.655
51.654
79.329
126.345
193.158
156.043
103.343
21.540
Employees
4
4
4
3
4
3
3
3
3
3
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity as found at the Ministry of Finance. The data provides the evolution of the company during this period regarding the increases and possibly decreases recorded.
In the last year of activity, the sales decreased by -26.1%, from 397.713 euro in the year 2023, to 292.167 euro in 2024.
The Net Profit decreased by -81.226 euro, from 103.343 euro in 2023, to 21.540 in the last year.
Check the financial reports for the company - Sabin & Weil Rx Srl
Financial Rating - SABIN & WEIL RX SRL
See the company's note based on the submitted financial data, relative to the industry of which it is a part.
Financial Rating
Payment Limits - Sabin & Weil Rx Srl
See the company's payment capacity for situations in which you conclude contracts with payment terms.
Check Payment Limits
Prob. of insolvency - Sabin & Weil Rx Srl
It determines the risk of insolvency based on the submitted accounting balance.
Insolvency Probability
Financial Reports - Sabin & Weil Rx Srl
Check all the financial reports of the company and know the risks in collaboration with it.
Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.
Debts, Equity, Inventories, Receivables, Accounts, Assets -
Sabin & Weil Rx Srl - CUI 16960515
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Fixed Assets
27.721
104.102
214.127
184.011
154.840
328.081
412.895
422.632
663.174
700.580
Current Assets
76.147
182.786
66.209
130.406
182.605
131.842
284.815
293.229
176.538
107.395
Inventories
27.991
22.356
39.302
47.550
50.138
28.314
41.669
65.622
36.136
49.983
Receivables
10.041
137.408
10.222
10.034
74.072
13.954
17.075
43.455
96.415
29.735
Cash
2.120
2.981
16.686
72.822
58.395
89.574
226.071
184.152
43.987
27.677
Shareholders Funds
76.006
71.368
167.816
216.390
291.529
412.347
596.361
156.092
258.962
279.054
Social Capital
45
45
44
43
42
41
40
41
40
40
Debts
27.863
215.519
112.520
98.026
45.915
47.576
101.349
559.769
580.751
529.025
Income in Advance
0
0
0
0
0
0
0
0
0
0
Exchange rate - RON
4.9743
4.9465
4.9315
4.9468
4.8371
4.7454
4.6535
4.5681
4.4908
4.445
Main CAEN
"8623 - 8623"
CAEN Financial Year
8623
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of
107.395 euro in 2024 which includes Inventories of
49.983 euro, Receivables of
29.735 euro and cash availability of
27.677 euro.
The company's Equity was valued at
279.054 euro, while total Liabilities amounted to
529.025 euro.
Equity increased by 21.540 euro, from 258.962 euro in 2023, to 279.054 in 2024.
Similar services useful for checking companies and business development.
SellNet
Get the contact details for any company and get in touch with it.
Sectoral Studies
Knows the market and develops its own development strategies according to sectorial data.
Databases
Export in excel files the data of the companies selected according to the desired criteria.
Import - Export
Find importers and exporters according to the type of activity and the countries in which they carry it out.
Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.
Comments - Sabin & Weil Rx Srl